Invesco NASDAQ Biotech UCITS ETF | SBIORegistrer dig for at låse op for ratings |
Fondens performance | 31-05-2025 |
Vækst af 1.000 (DKK) | Avanceret graf |
![]() | Fond | 7,0 | -6,1 | 2,8 | 4,6 | -13,5 |
![]() | +/-Kat | 10,1 | 6,7 | 1,5 | 2,8 | -0,2 |
![]() | +/-Indeks | 0,1 | -3,0 | -7,4 | 6,6 | -2,2 |
Kategori: Sektor - Bioteknologi, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Biotechnolo... |
Oversigt | ||
Closing Price 06-06-2025 | USD 44,20 | |
Kursændring 1 dag | 1,54% | |
Morningstar Kategori™ | Sektor - Bioteknologi, Aktier | |
Omsætning | 115379 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BQ70R696 | |
Markedsværdi i alt (mio.) 05-06-2025 | USD 261,79 | |
Seneste TNA(mio.) 05-06-2025 | USD 261,79 | |
Løbende omkostning 21-11-2024 | 0,40% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Invesco NASDAQ Biotech UCITS ETF | SBIO |
The investment objective of the Fund is to achieve the total return performance of the NASDAQ Biotechnology Index (the "Reference Index") less fees, expenses and transaction costs. The Reference Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market®. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
- - | ||
Startdato 06-11-2014 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
NASDAQ Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Invesco NASDAQ Biotech UCITS ETF | SBIO | 30-04-2025 |
|
|
Top 5 placeringer | Sektor | % |
TRS NASDAQ Biotechnology TR USD | ![]() | 100,00 |
![]() | ||
![]() ![]() ![]() | ||
Invesco NASDAQ Biotech UCITS ETF | SBIO |